Clinical Trial Search

Primary: Headache Disability Inventory (HDI) — 14.3 score on a scale — p=<.0001

Primary: Assessment of Recruitment Rate — 1.1; 0.6 participants per month

Primary: Embolic Tracks

Primary: Subject Self-examination of Skin Irritation — 1.0 scores on a scale

Primary: Percentage of Participants With Reduction of Migraine Headache at 2 Hours Post Treatment — 66; 40 Participants

Primary: 30 Minute Pain Score — 3; 3; 3 score on a scale

Primary: Migraine Headache Index (MHI) at 1 Year — 7.81; 3.73 index score

Primary: Number of Subjects Reporting Headache Relief at the 2 Hour Post Treatment Assessment. Relief Was Measured as a 2-point Change on a 4-point Scale (0=None, 1=Mild…

Primary: Reduction in Days of Headache Pain With Treatment of Memantine or Valproate in the Preventive Management of Episodic Migraine. — 5.35; 5.31; 0.77; 0.93 Migraine days by…

Primary: Number of Participants With Sustained Headache Relief Assessed by Self-evaluation — 40; 38 Participants

Primary: Gestational Age at Delivery — 271; 273 Gestational days — p=0.160

Primary: Incidence of Fasting-induced Headache of Any Intensity — 12; 18 participants — p=0.172

Primary: Visual Analog Scale (VAS) — 4.15; 7.46 Score (0-10)

Primary: Change in Migraine Characteristics — 43; 2; 17 Participants

Primary: Migraine Functional Impairment as Measured by Score on the Headache Impact Test 6 (HIT6) Scale — 59; 56 units on a scale